The United Arab Emirates has established comprehensive guidelines to ensure the ethical and scientific integrity of clinical trials involving investigational products and medical devices. These guidelines apply to all clinical studies conducted within the UAE, including both interventional and non-interventional trials.

Whether you are conducting a pharmaceutical trial, evaluating a new medical device, or launching a post-market clinical follow-up study, adherence to the national regulatory framework is essential.

Who Should Use These Guidelines?

These guidelines are designed for:

• Clinical researchers and investigators
  
  
• Medical device manufacturers
  
  
• Pharmaceutical companies
  
  
• Contract Research Organizations (CROs)
  
  

Academic and research institutions operating in the UAE

Scope of the Guidelines

The document outlines standards for:

• Ethical approval and informed consent
  
  
• Study design and methodology
  
  
• Risk management and patient safety
  
  
• Good Clinical Practice (GCP) adherence
  
  
• Regulatory submissions for both drugs and medical devices
  
  

It also covers investigational medical device trials, a growing area of innovation and regulatory attention in the UAE.

Why Compliance Matters

Ensuring your study complies with UAE regulations:

• Speeds up the approval process
  
  
• Enhances credibility with regulatory authorities
  
  
• Reduces delays due to non-compliance
  
  
• Promotes patient safety and data integrity